GW&K Investment Management LLC Has $43.53 Million Holdings in Balchem Corporation (NASDAQ:BCPC)

GW&K Investment Management LLC cut its position in shares of Balchem Corporation (NASDAQ:BCPC - Free Report) by 3.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 262,253 shares of the basic materials company's stock after selling 8,556 shares during the period. GW&K Investment Management LLC owned 0.80% of Balchem worth $43,534,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in BCPC. Covestor Ltd boosted its position in Balchem by 93.8% during the fourth quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock worth $26,000 after acquiring an additional 76 shares during the last quarter. Federated Hermes Inc. acquired a new position in shares of Balchem in the fourth quarter valued at approximately $33,000. Versant Capital Management Inc grew its holdings in Balchem by 534.2% during the 1st quarter. Versant Capital Management Inc now owns 241 shares of the basic materials company's stock worth $40,000 after acquiring an additional 203 shares in the last quarter. CWM LLC boosted its holdings in shares of Balchem by 34.0% in the 1st quarter. CWM LLC now owns 520 shares of the basic materials company's stock valued at $86,000 after buying an additional 132 shares in the last quarter. Finally, Huntington National Bank boosted its holdings in shares of Balchem by 30.9% in the 4th quarter. Huntington National Bank now owns 661 shares of the basic materials company's stock valued at $108,000 after buying an additional 156 shares in the last quarter. 87.91% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

BCPC has been the subject of several research reports. HC Wainwright set a $180.00 price target on shares of Balchem and gave the company a "buy" rating in a research report on Monday, April 28th. Wall Street Zen downgraded shares of Balchem from a "buy" rating to a "hold" rating in a research report on Wednesday, May 21st.

Balchem Price Performance

Shares of NASDAQ:BCPC traded up $0.18 on Monday, reaching $153.02. 125,681 shares of the company were exchanged, compared to its average volume of 143,675. The firm has a market cap of $4.99 billion, a price-to-earnings ratio of 36.70, a price-to-earnings-growth ratio of 3.30 and a beta of 0.89. Balchem Corporation has a 1-year low of $145.70 and a 1-year high of $186.03. The company has a 50-day moving average of $163.15 and a 200-day moving average of $162.67. The company has a current ratio of 2.44, a quick ratio of 1.40 and a debt-to-equity ratio of 0.18.

Balchem (NASDAQ:BCPC - Get Free Report) last released its earnings results on Thursday, April 24th. The basic materials company reported $1.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.25 by ($0.03). Balchem had a return on equity of 12.01% and a net margin of 14.16%. The company had revenue of $250.52 million during the quarter, compared to analyst estimates of $245.70 million. During the same period in the prior year, the business posted $1.03 earnings per share. Balchem's revenue was up 4.5% on a year-over-year basis. Equities analysts forecast that Balchem Corporation will post 4.64 earnings per share for the current fiscal year.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.